Skip to content

Survivorship Care Plans in a Community Oncology Practice

Feasibility of Delivering Electronic Health Record (EHR)-Based Survivorship Care Plans and Planning to Cancer Survivors in a Community Oncology Practice

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03028584
Enrollment
30
Registered
2017-01-23
Start date
2017-09-11
Completion date
2018-03-23
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colorectal Cancer, Prostate Cancer

Keywords

BrCa, PrCa, CRCa

Brief summary

This is a two part observational study evaluating the feasibility of implementing an EHR-based model within a community oncology practice.

Detailed description

Part 1: The research team will use a sociotechnical work systems model, developed by researchers at the University of Wisconsin (UW) Systems Engineering Initiative for Patience Safety (SEIPS), to guide analysis of the work system barriers and facilitators to implementing an EHR-based care planning model in community oncology practice, collected from direct observations. Part 2: The research team will measure reach/maintenance (percentage of survivors with EHR-based survivorship care plans (SCPs) over a 9-month time period) and impact (pre/post survey of patient satisfaction and perceived care coordination).

Interventions

BEHAVIORALSurvey

Subjects (cancer patients and clinicians) will complete up to 2 surveys.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Clinicians: Provide cancer care to BrCa, CRCa or PrCa * Clinicians: Are a physician, advanced practice practitioner, nurse, or equivalent * Patients: Have a diagnosis of breast, colorectal, or prostate cancer for which and EHR-based SCP will be provided * Patients: Have been treated with curative intent (e.g. surgery, chemotherapy and/or radiation therapy) for a Stage 1-3 cancer diagnosis * Patients: Have received some part of active cancer treatment * Patients: Have complete active treatment (defined as surgery, chemotherapy, and/or radiation therapy). HER2-based and endocrine therapies may be ongoing and do NOT need to have been completed

Exclusion criteria

* Unable to complete or unwilling to answer questions in English * Patients: Received all active cancer treatment elsewhere (e.g. observation - only patients) * Patients: Have metastatic cancer

Design outcomes

Primary

MeasureTime frameDescription
EHR-based SCPs and care planningUp to 2 yearsAsses whether barriers to EHR-based SCPs and care planning have been mitigated, based on clinician survey.

Secondary

MeasureTime frameDescription
Feasibility of providing EHR-based care planning, measured by SCP provision ratesUp to 2 yearsMeasured by SCP provision rates (percentage of survivors with EHR-based SCPs)
Feasibility of providing EHR-based care planning, measured by the EHRUp to 2 yearsMeasured by survivor access to SCPs, per the EHR
Self-reported change in satisfaction, using surveyUp to 2 yearsThe impact of providing EHR-based care planning measured in change of satisfaction with perceived care coordination (assessed prior to and at 4 weeks after SCP provision)
Impact of providing EHR-based care planningUp to 2 yearsMeasured by reported SCP usability, usefulness, and content (assessed prior to and at 4 weeks after SCP provision)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026